Particularities of hemostasis changes in COVID-19 patients.
Creative Cardiology
; 15(1):5-8, 2021.
Artigo
em Russo
| EMBASE | ID: covidwho-20244189
ABSTRACT
COVID-19 infection is characterized by different clinical presentations. The thrombotic complications play the leading role in COVID-19 infection. SARS-CoV-2 virus can activate hemostasis at different levels pulmonary tissue damage with subsequent plasma coagulation activation;local endothelial dysfunction and platelet activation during the course of the disease. Routine use of the anticoagulation treatment seems reasonable in hospitalized patients with COVID-19.Copyright © Creative Cardiology 2021.
covid-19; endothelial dysfunction; plasma coagulation; platelet activation; anticoagulant therapy; article; blood clotting; coronavirus disease 2019; hemostasis; hospital patient; human; lung injury; nonhuman; Severe acute respiratory syndrome coronavirus 2; thrombocyte activation; thrombosis; anticoagulant agent
Texto completo:
Disponível
Coleções:
Bases de dados de organismos internacionais
Base de dados:
EMBASE
Tipo de estudo:
Estudo prognóstico
Idioma:
Russo
Revista:
Creative Cardiology
Ano de publicação:
2021
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS